NEW YORK, July 11, 2023 /PRNewswire/ — Intelligent Retinal Imaging Systems (IRIS), a leader in retinal screening technology, today announced a partnership with AEYE Health, a leading artificial intelligence company for retinal imaging and diagnostics. Under the agreement, IRIS will license AEYE Diagnostic Screening (AEYE-DS) from AEYE Health, which is an FDA-cleared AI technology that seamlessly integrates with the IRIS Solution.

Read more here.